Treatment Outcomes of Patients Switching From an Injectable Drug to Bedaquiline During Short Standardized Treatment for Multidrug-resistant Tuberculosis in Mozambique
2019 ◽
Vol 69
(10)
◽
pp. 1809-1811
◽
Keyword(s):
Mdr Tb
◽
Abstract Bedaquiline was recommended by the World Health Organization as the preferred option in treatment of multidrug-resistant tuberculosis (MDR-TB) with long regimens. However, no recommendation was given for the short MDR-TB regimen. Data from our small cohort of patients who switched from injectable drug to bedaquiline suggest that a bedaquiline-based short regimen is effective and safe.
2019 ◽
Vol 23
(10)
◽
pp. 1050-1054
2019 ◽
Vol 6
◽
pp. 204993611986473
◽
2016 ◽
Vol 194
(8)
◽
pp. 1028-1029
◽
2016 ◽
Vol 25
(139)
◽
pp. 29-35
◽
2021 ◽
2014 ◽
Vol 45
(1)
◽
pp. 150-160
◽
2018 ◽
Vol 39
(03)
◽
pp. 310-324
◽
2018 ◽
Vol 51
(3)
◽
pp. 1702467
◽